ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Following Federal Trade Commission approval, Agilent has completed its $1.5 billion acquisition of fellow instrument maker Varian, advancing its strategy to become a leader in bioanalytical instrumentation. Completion of the deal, struck in July 2009, was delayed as the two awaited government clearances. To satisfy European regulators, Agilent earlier agreed to sell its micro gas chromatography business to Switzerland’s Inficon and three Varian businesses to Bruker (C&EN, March 15, page 28).
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter